Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

NCT00183391 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

232

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG: Atomoxetine
DRUG: Methylphenidate

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]